Literature DB >> 3649203

Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.

A E De Almeida, M De Uzeda.   

Abstract

The in vitro activity of metronidazole, chloramphenicol, clindamycin, cefoxitin, and carbenicillin was tested by an agar dilution method against 228 strains of the Bacteroides fragilis group isolated from human intestinal microbiota during 1981 and 1982. All the strains were susceptible to metronidazole. Resistance rates for chloramphenicol, clindamycin, cefoxitin, and carbenicillin were 2, 37, 21, and 13%, respectively.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3649203      PMCID： PMC174789          DOI： 10.1128/AAC.31.4.617

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

Review 2.  Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Authors:  J Birnbaum; E O Stapley; A K Miller; H Wallick; D Hendlin; H B Woodruff
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

3.  Bacteroides fragilis resistant to metronidazole after long-term therapy.

Authors:  H R Ingham; S Eaton; C W Venables; P C Adams
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

4.  Bacteroides fragilis resistant to the administration of clindamycin.

Authors:  J S Salaki; R Black; F P Tally; J W Kislak
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

5.  New medium for selection and presumptive identification of the Bacteroides fragilis group.

Authors:  S J Livingston; S D Kominos; R B Yee
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

6.  Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors:  F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

7.  Properties of a new penicillinase type produced by Bacteroides fragilis.

Authors:  K Sato; Y Matsuura; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

8.  Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors:  G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

9.  Bacteroides fragilis resistance to clindamycin in vitro.

Authors:  A Sosa; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191
  9 in total
  7 in total

Review 1.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors:  L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

3.  Rationale for selective use of anaerobic blood cultures.

Authors:  A J Morris; M L Wilson; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

4.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Authors:  P Turgeon; V Turgeon; M Gourdeau; J Dubois; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

6.  In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.

Authors:  K Watanabe; K Ueno; N Kato; Y Muto; K Bandoh; Y Tanaka; R Jotwani; M Goto; K Shimada; K Shimizu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

7.  Distribution, detection of enterotoxigenic strains and antimicrobial drug susceptibility patterns of bacteroides fragilis group in diarrheic and non-diarrheic feces from brazilian infants.

Authors:  Débora Paula Ferreira; Vânia Lúcia Silva; Danielle Aparecida Guimarães; Cíntia Marques Coelho; Danielle Alves Gomes Zauli; Luiz Macêdo Farias; Maria Auxiliadora Roque Carvalho; Claudio Galuppo Diniz
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.